Dr. Stephen Liu joins ALKtALK on June 30, 2024

Dr. Stephan Liu is an expert lung cancer medical oncologist and a researcher focused on the development of novel therapeutic agents and innovative combinations for patients. Dr. Liu strongly believes that all patients deserve the opportunity to benefit from the latest cancer research advances and conducts research that contributes to our understanding and treatments.
In this ALKtALK, Dr. Liu shared some background on the discovery of ALK-positive cancer back in 2007, the development of ALK treatments, and where we are now following the latest ALK research unveiled at recent #ASCO24 industry conference. Dr. Liu answered a wide range of questions on managing everything from doses, weight gain, frequency of scans, plus the use of liquid biopsies and more. You'll want to hear all that Dr. Liu had to share - we walked away better educated, informed and inspired.

[@ulrichpalm8359]

Thank you very much for these profound explanations about the effects of ALK+ drugs. Dr. Liu is able to explain so clearly and share his extensive knowledge from medical practice with us. This helps us a lot in weighing up whether to switch from alectinib to lorlatinib after the Crown study. Many greetings from Germany and many thanks to everyone who helped make this video possible.